Report me for selling fake medicine? Why are you crying when your illness relapses?

……

……

"Sell it, but it certainly won't be for 1000 billion."

"Hmm...it could also be 1000 billion, but it's 1000 billion US dollars."

"As long as you give me $1000 billion now, I can sell this drug patent at any time. I can transfer it whenever I want."

Faced with this question, Chen Xuan responded frankly.

But the amount he said so calmly left everyone stunned.

The whole place fell silent in an instant, so quiet that you could hear a pin drop.

And in the next moment, everyone couldn't help but explode.

"Fuck, did I hear that right? $1000 billion?"

"Oh my god, Chen Xuan is kidding, right? I know 1000 billion is a bit low, but isn't $1000 billion too much?"

"Hiss, if he really sold the formula for the lung cancer drug, he would have become the richest man in China, and the richest man by a wide margin."

"That's different. The other richest people's figures are all based on stock market value, which is quite inflated, but his $1000 billion is real cash."

"Chen Xuan is awesome. His words always make me drop my jaw. I wouldn't even dream of $1000 billion."

"When he said $1000 billion, no one believed him. But now he's achieved it. Maybe $1000 billion is really possible."

"Some drugs can indeed generate sales of hundreds of billions of dollars, but I wonder if a lung cancer drug can possibly do that."

Everyone at the scene was discussing excitedly.

Everyone was extremely shocked by the 100 billion US dollars that Chen Xuan mentioned.

Although everyone believes that the value of the lung cancer drug is far more than 1000 billion yuan, they did not believe him before, but now they all know that they have been slapped in the face.

But even so, they still find it hard to believe that a specific drug for lung cancer can create a $1000 billion myth. No matter how great the market potential of this drug is, it is hard to believe that it will be worth $1000 billion.

Historically, there have indeed been drugs that have generated sales of over $1000 billion, but they still think it is incredible.

It is hard for them to believe that a new drug can achieve this level of success. It requires the right time, place and people, and the drug must have been on the market for many years without any competition to generate sales of hundreds of billions of dollars.

In the decades since the development of modern medicine, there are still few drugs that can do this.

For a drug with sales of hundreds of billions, it is not an exaggeration to say that it is one in a million.

In this case, the $1000 billion that Chen Xuan mentioned was difficult for them to accept.

Not only the onlookers, but even those pharmaceutical companies that still had a hopeful mentality, instantly lost this idea and did not even have the courage to bargain with him.

After all, the opening price is $1000 billion. Even if it can be bargained, how much can it be reduced?

You should know that there is no pharmaceutical company in China with a market value of more than 100 billion US dollars.

Chen Xuan’s drug patent exceeds the market value of these pharmaceutical companies, which is indeed hard to believe.

Even in the entire world, there are only a dozen or so pharmaceutical giants with a market value of more than $1000 billion.

Because of this, everyone thought that he had no intention of selling the patent for the lung cancer drug when he offered this price, but was just deliberately offering a sky-high price to scare away all pharmaceutical companies.

But that’s not what Chen Xuan meant.

Or maybe he did have this idea, but he didn't ask his sister-in-law for help.

He knew that $1000 billion was a price that no pharmaceutical company could accept, but he also believed that the lung cancer drug was worth $1000 billion.

"You think $1000 billion is an exaggeration, but I don't think so."

"Lijinto entered the market a decade after the first statin, when there were already three similar drugs with annual sales exceeding $10 billion."

"Even so, within three years of its launch, Lijinto surpassed similar drugs and became the first drug in the world to exceed $100 billion in annual sales, with cumulative sales exceeding $1500 billion."